• Goldman Sachs has revised its price target for Xylem Inc (NYSE: XYL) to $158, indicating a potential increase of about 24.64%.
• Xylem reported fourth-quarter earnings per share of $1.42 and quarterly sales of $2.397 billion, surpassing expectations.
• The company's forecast for fiscal year 2026 adjusted earnings per share and sales fell short of market estimates, leading to a 2.1% decrease in share price following the earnings report.

Xylem Inc (NYSE: XYL), a leading global water technology company, provides innovative solutions for water and wastewater management. Competing with major industry players like Danaher Corporation and Pentair plc, Xylem operates in various segments, including water infrastructure, applied water, and measurement and control solutions.

On February 11, 2026, Goldman Sachs set a price target of $158 for XYL, down from a previous target of $175. At the time, the stock was priced at $126.77, suggesting a potential increase of about 24.64%. This adjustment comes despite Xylem's strong fourth-quarter earnings, where they reported earnings per share of $1.42, slightly above the consensus estimate of $1.41.

Xylem's quarterly sales reached $2.397 billion, surpassing the expected $2.374 billion. However, the company's forecast for fiscal year 2026 adjusted earnings per share is between $5.35 and $5.56, which is below market estimates of $5.56. Additionally, Xylem anticipates sales between $9.1 billion and $9.2 billion, falling short of the expected $9.331 billion.

Despite these forecasts, Xylem's CEO, Matthew Pine, expressed satisfaction with the company's performance, highlighting record full-year revenue and strong demand across major markets. However, following the earnings report, XYL shares fell by 2.1% to $126.24, and analysts adjusted their price targets accordingly.

Currently, XYL is trading at $126.77, reflecting a decrease of 1.67% or $2.15. The stock has fluctuated between $125.92 and $131.73 today. Over the past year, XYL has seen a high of $154.27 and a low of $100.47. The company's market capitalization is approximately $30.86 billion, with a trading volume of 2,951,416 shares on the NYSE.